Showing results (271-280 of 527) with videos related to
Sort By:
Pageof 53
Journal of Immunology (Baltimore, Md. : 1950)|August 17, 2011
HIV-DNA priming alters T cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectableStephen C De Rosa, Evan P Thomas, John Bui, et al.Frontiers in Immunology|June 30, 2020
Structure-Based Design of Nipah Virus Vaccines: A Generalizable Approach to Paramyxovirus Immunogen DevelopmentRebecca J Loomis, Guillaume B E Stewart-Jones, Yaroslav Tsybovsky, et al.Journal of Virology|September 16, 2004
Signaling through the prostaglandin I2 receptor IP protects against respiratory syncytial virus-induced illnessKoichi Hashimoto, Barney S Graham, Mark W Geraci, et al.Journal of Virology|February 14, 2006
Human immunodeficiency virus (HIV) vaccine trials: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodiesSurender Khurana, James Needham, Bonnie Mathieson, et al.Science Translational Medicine|June 22, 2022
Elicitation of pneumovirus-specific B cell responses by a prefusion-stabilized respiratory syncytial virus F subunit vaccineEmily Phung, Lauren A Chang, Maryam Mukhamedova, et al.Vaccine|March 30, 2007
Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccineAndrew T Catanzaro, Mario Roederer, Richard A Koup, et al.Cell|May 7, 2020
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid AntibodiesDaniel Wrapp, Dorien De Vlieger, Kizzmekia S Corbett, et al.Clinical Nuclear Medicine|March 14, 2017
Lymph Node Activation by PET/CT Following Vaccination With Licensed Vaccines for Human PapillomavirusesEmily E Coates, Pamela J Costner, Martha C Nason, et al.Plos Pathogens|May 3, 2013
Development of a highly protective combination monoclonal antibody therapy against Chikungunya virusPankaj Pal, Kimberly A Dowd, James D Brien, et al.The Journal of Infectious Diseases|August 6, 2004
Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160Deborah Lee, Barney S Graham, Ya-Lin Chiu, et al.Pageof 53